105 related articles for article (PubMed ID: 3075631)
1. Correlation of in vitro Fc receptor assay with in vivo mouse foot pad method.
Jagannathan R; Patil D; Mahadevan PR
Indian J Lepr; 1988 Oct; 60(4):517-25. PubMed ID: 3075631
[TBL] [Abstract][Full Text] [Related]
2. A rapid method for viability and drug sensitivity of Mycobacterium leprae cultured in macrophages and using fluorescein diacetate.
Bhagria A; Mahadevan PR
Indian J Lepr; 1987; 59(1):9-19. PubMed ID: 2440960
[TBL] [Abstract][Full Text] [Related]
3. Mouse foot-pad studies with M. leprae--effect of desoxy fructo serotonin (DFS) and related compounds.
Balakrishnan S; Mester L; Venkataramaniah HN; Bhatia VN
Indian J Lepr; 1985; 57(2):323-8. PubMed ID: 3908578
[TBL] [Abstract][Full Text] [Related]
4. Comparison of radiometric macrophage assay and the mouse foot pad infection for the evaluation of Mycobacterium leprae sensitivity/resistance to dapsone.
Sathish M; Rees RJ; Seshadri PS; Nath I
Int J Lepr Other Mycobact Dis; 1985 Sep; 53(3):378-84. PubMed ID: 3900244
[TBL] [Abstract][Full Text] [Related]
5. Activity of phenazine analogs against Mycobacterium leprae infections in mice.
Van Landingham RM; Walker LL; O'Sullivan JF; Shinnick TM
Int J Lepr Other Mycobact Dis; 1993 Sep; 61(3):406-14. PubMed ID: 8228439
[TBL] [Abstract][Full Text] [Related]
6. Adenosine triphosphate content of Mycobacterium leprae from leprosy patients.
Dhople AM
Int J Lepr Other Mycobact Dis; 1984 Jun; 52(2):183-8. PubMed ID: 6373626
[TBL] [Abstract][Full Text] [Related]
7. Studies on sulphone resistant strains of M. leprae in field and institutionalized cases of leprosy.
Balakrishnan S; Seshadri PS; Neelan PN; Venkataramaniah HN; Harikrishnan S; Bhatia VN
Lepr India; 1983 Jan; 55(1):71-5. PubMed ID: 6348413
[TBL] [Abstract][Full Text] [Related]
8. The mouse foot-pad technique for cultivation of Mycobacterium leprae.
Levy L; Ji B
Lepr Rev; 2006 Mar; 77(1):5-24. PubMed ID: 16715686
[TBL] [Abstract][Full Text] [Related]
9. A Mycobacterium leprae isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin.
Matsuoka M; Kashiwabara Y; Namisato M
Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):452-5. PubMed ID: 11332288
[TBL] [Abstract][Full Text] [Related]
10. Application of the mouse foot-pad technique in immunologically normal mice in support of clinical drug trials, and a review of earlier clinical drug trials in lepromatous leprosy.
Levy L
Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4 Suppl):823-9. PubMed ID: 3325574
[No Abstract] [Full Text] [Related]
11. [Multiplication of mycobacterium leprae in nude mice].
Wang HY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Oct; 11(5):358-62. PubMed ID: 2534616
[TBL] [Abstract][Full Text] [Related]
12. Assessment of viability by normal mouse foot-pad and bacillary ATP bioluminescence assay in multibacillary cases treated with an MDT regimen using conventional as well as newer drugs like minocycline and ofloxacin.
Gupta UD; Katoch K; Singh HB; Natrajan M; Sharma VD; Katoch VM
Indian J Lepr; 2000; 72(4):437-42. PubMed ID: 11212477
[TBL] [Abstract][Full Text] [Related]
13. Are all nonsolid Mycobacterium leprae dead? Does a negative finding in the mouse foot pad indicate that there is actually no growth of M. leprae in the animals?
Chang YT
Int J Lepr Other Mycobact Dis; 1977; 45(3):235-40. PubMed ID: 336555
[TBL] [Abstract][Full Text] [Related]
14. The presence of systemic and local activated macrophages in mice infected in the foot pad with Mycobacterium leprae and M. marinum.
Krahenbuhl JL; Welch TM; Levy L
Int J Lepr Other Mycobact Dis; 1976; 44(1-2):206-15. PubMed ID: 776858
[TBL] [Abstract][Full Text] [Related]
15. Viability determination of M.leprae: comparison of normal mouse foot pad and bacillary ATP bioluminescence assay.
Gupta UD; Katoch K; Natarajan M; Sharma VD; Sharma RK; Shivannavar CT; Katoch VM
Acta Leprol; 1997; 10(4):209-12. PubMed ID: 9447254
[TBL] [Abstract][Full Text] [Related]
16. Mouse foot pad growth of M. leprae in relation to bacteriological index.
Bhatia VN; Balakrishnan S; Venkataramaniah HN; Harikrishnan S
Lepr India; 1983 Apr; 55(2):247-51. PubMed ID: 6355651
[TBL] [Abstract][Full Text] [Related]
17. Host-pathogen interaction--new in vitro drug test systems against Mycobacterium leprae--possibilities and limitations.
Mahadevan PR; Jagannathan R; Bhagaria A; Vejare S; Agarwal S
Lepr Rev; 1986; 57 Suppl 3():182-200. PubMed ID: 3553811
[No Abstract] [Full Text] [Related]
18. Susceptibility of strains of Mycobacterium leprae isolated prior to 1977 from patients with previously untreated lepromatous leprosy.
Shepard CC; Rees RJ; Levy L; Pattyn SR; Baohong J; Dela Cruz EC
Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):11-5. PubMed ID: 3519796
[TBL] [Abstract][Full Text] [Related]
19. Comparison of radiometric macrophage assay and fluorescein diacetate/ethidium bromide staining for evaluation of M. leprae viability.
Harshan KV; Prasad HK; Chopra NK; Mishra RS; Gogiya P; Nath I
Int J Lepr Other Mycobact Dis; 1987 Jun; 55(2):316-21. PubMed ID: 2439621
[TBL] [Abstract][Full Text] [Related]
20. Minimum inhibitory and bactericidal dosages of rifampici against Mycobacterium leprae in the mouse foot pad: relationship to serum rifampicin concentrations.
Holmes IB
Int J Lepr Other Mycobact Dis; 1974; 42(3):289-96. PubMed ID: 4617716
[No Abstract] [Full Text] [Related]
[Next] [New Search]
